Safety and efficacy of rituximab in patients with refractory myositis and overlap myositis.

Trial Profile

Safety and efficacy of rituximab in patients with refractory myositis and overlap myositis.

Completed
Phase of Trial: Phase II

Latest Information Update: 17 Oct 2014

At a glance

  • Drugs Rituximab (Primary)
  • Indications Autoimmune disorders
  • Focus Therapeutic Use
  • Most Recent Events

    • 17 Oct 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top